Pediatric Cancer Biomarker Market to Surpass USD 1.63 Billion by 2032, Driven by Advances in Precision Oncology and Early Diagnosis – SNS Insider
U.S. Market Shows Robust Momentum, Accounting for Significant Global Share as Hospitals, Research Institutes, and Biotech Firms Accelerate Biomarker-Driven Cancer…